MorphoSys's vision

MorphoSys is committed to develop exceptional new treatments for patients suffering from serious diseases. A leader in the field of therapeutic antibodies today, MorphoSys is driven by the ambition of creating the most valuable pipeline of biopharmaceuticals in the biotechnology industry.

Events

29. Fri
May

ASCO Annual Meeting

Chicago, Illinois, USA

Investor Contact

Dr. Sarah Fakih

Vice President/Head of Corporate Communications & Investor Relations

Phone: +49 89 89927 26663

Email Contact
LinkedIn-Profile

Dr. Julia Neugebauer

Director Corporate Communications & Investor Relations

Phone: +49 89 89927 179

Email Contact
LinkedIn-Profile